Immunogenicity 11973
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CAPN9
Transcript ID
uc001hua.1
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (664 aa)
MPYLY
1
RAPGP
6
QAHPV
11
PKDAR
16
ITHSS
21
GQSFE
26
QMRQE
31
CLQRG
36
TLFED
41
ADFPA
46
SNSSL
51
FYSER
56
PQIPF
61
VWKRP
66
GEIVK
71
NPEFI
76
LGGAT
81
RTDIC
86
QGELG
91
DCWLL
96
AAIAS
101
LTLNQ
106
KALAR
111
VIPQD
116
QSFGP
121
GYAGI
126
FHFQF
131
WQHSE
136
WLDVV
141
IDDRL
146
PTFRD
151
RLVFL
156
HSADH
161
NEFWS
166
ALLEK
171
AYAKL
176
NGSYE
181
ALKGG
186
SAIEA
191
MEDFT
196
GGVAE
201
TFQTK
206
EAPEN
211
FYEIL
216
EKALK
221
RGSLL
226
GCFID
231
TRSAA
236
ESEAR
241
TPFGL
246
IKGHA
251
YSVTG
256
IDQVS
261
FRGQR
266
IELIR
271
IRNPW
276
GQVEW
281
NGSWS
286
DRMAF
291
KDFKA
296
HFDKV
301
EICNL
306
TPDAL
311
EEDAI
316
HKWEV
321
TVHQG
326
SWVRG
331
STAGG
336
CRNFL
341
DTFWT
346
NPQIK
351
LSLTE
356
KDEGQ
361
EECSF
366
LVALM
371
QKDRR
376
KLKRF
381
GANVL
386
TIGYA
391
IYECP
396
DKDEH
401
LNKDF
406
FRYHA
411
SRARS
416
KTFIN
421
LREVS
426
DRFKL
431
PPGEY
436
ILIPS
441
TFEPH
446
QEADF
451
CLRIF
456
SEKKA
461
ITRDM
466
DGNVD
471
IDLPE
476
PPKPT
481
PPDQE
486
TEEEQ
491
RFRAL
496
FEQVA
501
GEDME
506
VTAEE
511
LEYVL
516
NAVLQ
521
KKKDI
526
KFKKL
531
SLISC
536
KNIIS
541
LMDTS
546
GNGKL
551
EFDEF
556
KVFWD
561
KLKQW
566
INLFL
571
RFDAD
576
KSGTM
581
STYEL
586
RTALK
591
AAGFQ
596
LSSHL
601
LQLIV
606
LRYAD
611
EELQL
616
DFDDF
621
LNCLV
626
RLENA
631
SRVFQ
636
ALSTK
641
NKEFI
646
HLNIN
651
EFIHL
656
TMNI
661
Mutation Information
DNA mutation:
None
Peptide Range:
120 ~ 144
Mut AA position:
132 (13 in Wild Type peptide)
Alignment
Wild Type:
"DQSFGPGYAGIFHFQFWQHSEWLDV
||||||||||||.||||||||||||
Mutant:
DQSFGPGYAGIFYFQFWQHSEWLDV"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CAPN9
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay